Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Business Alignment PCLBKK:BIZ 91 PB Ratio is 4.21 as of Aug. 18, 2026, which is 53% above its 10-year median of 2.76. GuruFocus rates BKK:BIZ with a GF Score™ of 91/100 and a GF Value™ of ฿5.41 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 782 Medical Devices & Instruments companies, Business Alignment PCL ranks worse than 67.01% on this metric.
Business Alignment PCL stock PB Ratio (=3.34) is close to 3-year high of 3.45.
The historical rank and industry rank for Business Alignment PCL's PB Ratio or its related term are showing as below:
BKK:BIZ'
s PB Ratio Range Over the Past 10 Years
Min: 1.58 Med: 2.76 Max: 7.21
Current: 3.34
During the past 11 years, Business Alignment PCL's highest PB Ratio was 7.21. The lowest was 1.58. And the median was 2.76.
BKK:BIZ's PB Ratio is ranked worse than 67.01% of 782
companies
in the Medical Devices & Instruments industry
Industry Median: 2.145
vs BKK:BIZ: 3.34
During the past 12 months, Business Alignment PCL's average Book Value Per Share Growth Rate was 21.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 8.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 10.30% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 11.00% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Business Alignment PCL was 32.90% per year. The lowest was 1.20% per year. And the median was 8.75% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Business Alignment PCL's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Business Alignment PCL PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Business Alignment PCL's PB Ratio distribution charts can be found below:
* The bar in red indicates where Business Alignment PCL's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Business Alignment PCL (BKK:BIZ) has a PB Ratio of 4.21 as of Aug. 18, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Business Alignment PCL and its competitors. This is 53% above median its historical median of 2.76. Over the past decade, Business Alignment PCL's PB Ratio has ranged from 1.58 to 7.21. According to the industry distribution chart, Business Alignment PCL ranks #524 out of 782 companies in the Medical Devices & Instruments industry, placing it in the top 67%.
Is Business Alignment PCL's PB Ratio too high?
Business Alignment PCL's current PB Ratio of 4.21 is 53% above median its 10-year median of 2.76. Over the past 10 years, this metric has ranged from a low of 1.58 to a high of 7.21. The Medical Devices & Instruments industry median PB Ratio is 2.15. Business Alignment PCL's value of 4.21 is 96.3% above this industry median. Based on the distribution chart, Business Alignment PCL ranks #524 out of 782 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Business Alignment PCL has a GF Score™ of 91/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Business Alignment PCL's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Business Alignment PCL ranks #524 out of 782 companies for PB Ratio. This places Business Alignment PCL in the lower half of its industry. The industry median PB Ratio is 2.15. Business Alignment PCL's value of 4.21 is 96.3% above this benchmark. Historically, Business Alignment PCL's own PB Ratio has ranged from 1.58 to 7.21 over the past decade. While the company's 10-year median is 2.76 vs. the industry median of 2.15, Business Alignment PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.15, based on 782 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Business Alignment PCL's current PB Ratio of 4.21 is 96.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Business Alignment PCL and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Business Alignment PCL's current PB Ratio is 4.21, which is 53% above median its own 10-year median of 2.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Business Alignment PCL stock overvalued right now?
Based on GuruFocus' analysis, Business Alignment PCL (BKK:BIZ) is currently considered Modestly Overvalued. The stock's GF Value™ is ฿5.41, compared to a current price of ฿6.00 — trading 10.9% above its estimated fair value. The current PB Ratio is 4.21, which is 53% above median its 10-year median of 2.76 and 96.3% above the Medical Devices & Instruments industry median of 2.15. Business Alignment PCL's overall GF Score™ is 91/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Business Alignment PCL (BKK:BIZ), the current PB Ratio is 4.21 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Business Alignment PCL (BKK:BIZ) Overvalued in 2026?
Based on GuruFocus' analysis, Business Alignment PCL stock appears to be overvalued.
The current stock price of ฿6.00 is trading 10.9% above its estimated GF Value™ of ฿5.41.
GuruFocus considers Business Alignment PCL to be Modestly Overvalued.
Key valuation signals for BKK:BIZ:
PB Ratio: 4.21 (53% above median its 10-year median of 2.76)
GF Value™: ฿5.41 vs. price of ฿6.00 (10.9% above fair value)
Industry Position: 96.3% above the Medical Devices & Instruments median (#524 of 782)
No single metric tells the full story. See the BKK:BIZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Business Alignment PCL is engaged in the distribution and installation of medical equipment for cancer treatment through radiotherapy. The company operates through the sale of medical equipment segment which includes installation, repair, and maintenance. In addition, it also focuses on increasing the efficiency of medical equipment; and Hospital operations (specialized in cancer treatment). The company is a distributor for Radiotherapy products and Brachytheraphy products in Thailand and Cambodia. Geographically, it operates in the region of Thailand.
91GF Score
Get the complete analysis for BKK:BIZ
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BIZ has been successfully added to your 
